A Volumetric Method for Quantifying Atherosclerosis in Mice by Using MicroCT: Comparison to En Face

• David J. Lloyd ,

  * E-mail: dlloyd@amgen.com

  Affiliation Department of Metabolic Disorders, Amgen Inc., Thousand Oaks, California, United States of America

  ⨯
• Joan Helmering,

  Affiliation Department of Metabolic Disorders, Amgen Inc., Thousand Oaks, California, United States of America

  ⨯
• Stephen A. Kaufman,

  Affiliation Department of Pathology, Amgen Inc., Thousand Oaks, California, United States of America

  ⨯
• James Turk,

  Affiliation Department of Pathology, Amgen Inc., Thousand Oaks, California, United States of America

  ⨯
• Matt Silva,

  Affiliation Department of Research Imaging, Amgen Inc., Thousand Oaks, California, United States of America

  ⨯
• Sergio Vasquez,

  Affiliation Numira Biosciences, Salt Lake City, Utah, United States of America

  ⨯
• David Weinstein,

  Affiliation Numira Biosciences, Salt Lake City, Utah, United States of America

  ⨯
• Brad Johnston,

  Affiliation Numira Biosciences, Salt Lake City, Utah, United States of America

  ⨯
• Clarence Hale,

  Affiliation Department of Metabolic Disorders, Amgen Inc., Thousand Oaks, California, United States of America

  ⨯
• Murielle M. Véniant

  Affiliation Department of Metabolic Disorders, Amgen Inc., Thousand Oaks, California, United States of America

  ⨯